
Biore

Sunscreens
This formula needs extra consideration during pregnancy. Review the flagged ingredients with your healthcare professional.
31 of 31 ingredients rated
MamaSkin rates the recorded formula for Biore UV Aqua Rich Watery Essence Extreme Protection SPF50+ PA++++ as Medium risk (51/100). Discuss the flagged ingredients with a qualified healthcare professional before using this formula during pregnancy.
The recorded formula includes 4 ingredient entries with risk flags: Ethylhexyl Methoxycinnamate (Medium risk), BHT (Medium risk), Methylparaben (Medium risk), plus others listed in the breakdown. These are ingredient-level flags; they do not replace the stored product assessment or account for every formulation detail.
31 of 31 ingredient entries on this page have a recorded score, evidence summary and source text. That describes documentation coverage, not proof that the finished formula has been clinically tested during pregnancy.
How we assess productsThe recorded formula, with evidence behind each rating. Unmatched ingredients are marked Not assessed in grey.
Ethylhexyl methoxycinnamate (EHMC) is a UV-B filter (also called octinoxate/octyl methoxycinnamate). SCCS characterised EHMC as endocrine-active (oestrogenic activity and weak anti-androgenic activity in vitro and in vivo) and reviewed genotoxicity/reproductive toxicity datasets in its re-evaluation. Pregnancy-specific human outcome data for topical exposure are limited; the medium-risk signal is endocrine activity plus systemic exposure uncertainty with frequent, large-area use.
Sources: SCCS/1671/24: Ethylhexyl methoxycinnamate https://health.ec.europa.eu/publications/sccs-opinion-ethylhexyl-methoxycinnamate-ehmc-cas-no-5466-77-383834-59-7-ec-no-226-775-7629-661-9_en
Methylparaben is a preservative with weak endocrine activity in some experimental systems. After reviewing the available endocrine and toxicology evidence, SCCS/1652/23 concluded that methylparaben is safe in cosmetics up to 0.4% as acid, including up to 0.4% within permitted ester mixtures whose total does not exceed 0.8%. Pregnancy-specific human outcome data for repeated topical exposure remain limited. MamaSkin retains Medium Risk as a deliberately conservative pregnancy policy, not because SCCS found compliant cosmetic use unsafe.
Sources: SCCS/1652/23: Opinion on Methylparaben, final 14 December 2023 with 2024 corrigendum https://health.ec.europa.eu/publications/methylparaben-cas-no-99-76-3-ec-no-202-785-7_en; CIR: Amended Safety Assessment of Parabens as Used in Cosmetics https://www.cir-safety.org/supplementaldoc/amended-safety-assessment-parabens-used-cosmetics-0
BHT (butylated hydroxytoluene) is a lipophilic antioxidant used to protect oils from oxidation. Animal studies at high (primarily oral) doses show liver enzyme induction and related biochemical changes; endocrine-screening lines of evidence have also been evaluated in regulatory reviews. Pregnancy-specific human outcome data for topical cosmetic exposure are limited; the key signal is systemic toxicology at higher exposures and uncertainty for pregnancy-specific outcomes.
Sources: SCCS/1636/21: Butylated hydroxytoluene https://health.ec.europa.eu/publications/butylated-hydroxytoluene-bht_en
Umbrella term for an undisclosed fragrance blend. It’s not usually a pregnancy-specific concern at normal cosmetic use levels, but the exact components and concentrations aren’t fully disclosed on the label, so we score it more conservatively. If you prefer maximum transparency (or you’re sensitive to fragrance compounds), choose fragrance-free/unscented products.
Sources: SCCS: Fragrance allergens in cosmetic products https://health.ec.europa.eu/latest-updates/sccs-new-opinion-fragrance-allergens-cosmetic-products-2012-07-31_en
Water (Aqua) is the standard purified water used as a cosmetic solvent. It has no pregnancy-specific risk in normal topical use.
Sources: https://pubchem.ncbi.nlm.nih.gov/compound/Water, https://single-market-economy.ec.europa.eu/sectors/cosmetics/cosmetic-ingredient-database/cosing-glossary-ingredients_en
Volatile solvent used in some toners, sprays, and lightweight formulas. Reviewed cosmetic safety sources support current cosmetic use, with no pregnancy- or breastfeeding-specific topical concern identified in the material reviewed; the main practical issue is dryness, stinging, or barrier disruption in some users.
Sources: CIR: Safety Assessment of SD Alcohol 40, Benzyl Alcohol, and Denatured Alcohol in Cosmetic Products; EU CosIng / cosmetics regulatory inventory
Mineral ingredient used as a UV filter and skin protectant in many creams and mineral sunscreens. For typical topical use, systemic absorption is very low and it is generally considered acceptable in pregnancy and breastfeeding. If you prefer a cautious approach, avoid inhaling loose powders or spray formats.
Sources: General dermatology/obstetric guidance commonly lists mineral sunscreens (zinc oxide) as acceptable in pregnancy; exposure route considerations for powders/sprays.
Mineral absorbent and texture aid used to mattify and improve slip. Reviewed cosmetic safety sources support normal topical cosmetic use; this assessment does not cover deliberate inhalation of loose powder.
Sources: CIR: Safety Assessment of Silica and Silicates as Used in Cosmetics; EU CosIng / cosmetics regulatory inventory
This emollient ester improves slip and skin feel. Cosmetic Ingredient Review assessments support use in current cosmetic concentrations when formulated to be non-irritating; topical use is not identified as a pregnancy- or breastfeeding-specific concern. Some alkyl esters can increase penetration of other formula ingredients.
Sources: CIR: Safety Assessment of Alkyl Esters as Used in Cosmetics https://cir-safety.org/supplementaldoc/safety-assessment-alkyl-esters-used-cosmetics
Solvent and humectant commonly used in leave-on products. Not associated with pregnancy-specific concerns at cosmetic exposure levels.
Sources: Cosmetic Ingredient Review (US); Scientific Committee on Consumer Safety (EU)
UV filter used in sunscreens and day products to help absorb UVB radiation. Reviewed cosmetic safety and regulatory sources support current cosmetic use within applicable concentration limits, with no pregnancy- or breastfeeding-specific topical concern identified in the material reviewed.
Sources: EU CosIng Annex VI / UV filters; EU scientific opinion on Ethylhexyl Triazone (Uvinul T 150)
Modern UVA filter (often called Uvinul A+ or DHHB). Regulatory assessments have repeatedly evaluated this filter as safe in cosmetic products at concentrations up to 10%. The most recent SCCS advice focuses on controlling a manufacturing impurity (DnHexP) rather than on new toxicity of DHHB itself. Human biomonitoring data indicate low systemic exposure from normal sunscreen use, and current reviews do not identify specific reproductive or developmental toxicity signals at approved concentrations.
Sources: SCCP opinion referenced in Directive 2008/123/EC: concludes that Diethylamino Hydroxybenzoyl Hexyl Benzoate used at a maximum of 10% in cosmetic (including sunscreen) products does not pose a risk to the consumer. Regulatory summaries (e.g. CosLaw and CIRS Group updates, 2025) reviewing the SCCS DHHB opinion and reiterating that DHHB remains permitted up to 10% in EU cosmetics when impurity limits are respected.
Mineral platelet used to add shimmer and improve texture in makeup and skincare. Very low dermal absorption in typical topical use and generally considered acceptable in pregnancy and breastfeeding. If you prefer a cautious approach, avoid inhaling loose powders or sprays.
Sources: General cosmetic ingredient safety references for inert minerals/pigments; exposure route considerations for powders/sprays.
Emollient ester used for lightweight slip and a dry skin feel in makeup and skin care. Reviewed cosmetic ingredient references do not identify a pregnancy- or breastfeeding-specific concern for normal topical cosmetic use.
Sources: CIR cosmetic ingredient safety references for alkyl esters/emollient esters; EU CosIng / cosmetics regulatory inventory
dipentaerythrityl tri-polyhydroxystearate is an emollient lipid, ester, fatty-acid derivative, butter or hydrocarbon texture ingredient. Relevant cosmetic-family evidence supports use with normal purity and formulation controls. No pregnancy-specific concern was identified for ordinary topical exposure; source allergy or irritation can still occur where applicable.
Sources: CIR Safety Assessment of Alkyl Esters as Used in Cosmetics https://www.cir-safety.org/supplementaldoc/safety-assessment-alkyl-esters-used-cosmetics; CIR plant-oil and fatty-acid derivative assessments.
Silane coating and dispersion aid used on pigments and mineral particles. Reviewed cosmetic safety sources support normal topical use, with no pregnancy- or breastfeeding-specific topical signal identified in the material reviewed.
Sources: CIR: Safety Assessment of Alkoxyl Alkyl Silanes as Used in Cosmetics; EU CosIng / cosmetics regulatory inventory
Modern broad-spectrum UV filter (often known as Tinosorb S). It has a high molecular weight and is formulated to remain mainly in the outer skin layers, with very low systemic absorption at cosmetic use levels. EU regulatory assessments and independent risk–benefit reviews have evaluated this filter as safe up to 10% in sunscreens, with no specific reproductive or developmental toxicity signals identified in animals or humans at permitted concentrations.
Sources: European Union Cosmetic Products Regulation (Annex VI): Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine listed as an approved UV filter up to 10% in cosmetic products. Mikkelsen SH et al. “Survey and health assessment of UV filters” – Danish EPA, 2015: includes Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine and notes low systemic exposure at approved use levels.
This sorbitan fatty-acid ester is an emulsifier that helps oil and water phases remain mixed. The Cosmetic Ingredient Review concluded that sorbitan esters are safe in current cosmetic use; occasional contact reactions remain possible in sensitive users.
Sources: CIR: Safety Assessment of Sorbitan Esters as Used in Cosmetics https://www.cir-safety.org/supplementaldoc/safety-assessment-sorbitan-esters-used-cosmetics
Large polymer thickener, stabilizer and texture ingredient used in gels, creams and sunscreens. Systemic exposure from topical cosmetic use is expected to be low, with no pregnancy- or breastfeeding-specific concern identified in reviewed cosmetic references.
Sources: CIR cosmetic ingredient safety references for acrylates copolymers; EU CosIng / cosmetics regulatory inventory
A large synthetic polymer used to thicken and stabilise cosmetic emulsions. Related acrylate copolymers have low dermal absorption because of their molecular size, and cosmetic safety reviewers concluded that this polymer family is safe when formulas avoid irritation and residual monomers are appropriately controlled. Exact pregnancy-specific topical studies are limited, but no pregnancy-specific concern was identified for normal exposure to the finished polymer in a compliant cosmetic.
Sources: CIR: Amended Safety Assessment of Acrylates Copolymers as Used in Cosmetics https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6; CIR: Final Report on Acrylates Copolymer and Related Ingredients https://cir-reports.cir-safety.org/view-attachment/?id=c9cc1a17-8e74-ec11-8943-0022482f06a6
Low-viscosity isoparaffin emollient used for slip and lightweight texture. Reviewed cosmetic safety sources support normal topical use, with no pregnancy- or breastfeeding-specific topical signal identified in the material reviewed.
Sources: CIR: Safety Assessment of Isoparaffins as Used in Cosmetics / CIR Quick Reference Table (Isohexadecane); EU CosIng / cosmetics regulatory inventory
A grafted silicone-amide conditioning polymer. Its defined structure and related safety evidence support ordinary non-irritating topical use, without an identified pregnancy-specific concern.
Sources: https://patents.google.com/patent/US20160051452A1/en, https://www.cir-safety.org/sites/default/files/FAR_Methicones_032022.pdf
Nonionic emulsifier and solubilizer used to disperse oils in cosmetic formulas. Reviewed cosmetic safety sources support normal topical use, with no pregnancy- or breastfeeding-specific topical signal identified.
Sources: CIR: Safety Assessment of Polysorbates as Used in Cosmetics; EU CosIng / cosmetics regulatory inventory
Disodium EDTA is a chelating agent used to improve formula stability and performance; it is considered low concern in topical cosmetic use, with no known pregnancy or breastfeeding risks at typical concentrations.
Sources: CIR; EU/UK Cosmetics Regulation
This sorbitan fatty-acid ester is an emulsifier that helps oil and water phases remain mixed. The Cosmetic Ingredient Review concluded that sorbitan esters are safe in current cosmetic use; occasional contact reactions remain possible in sensitive users.
Sources: CIR: Safety Assessment of Sorbitan Esters as Used in Cosmetics https://www.cir-safety.org/supplementaldoc/safety-assessment-sorbitan-esters-used-cosmetics
Mineral ingredient used in some cosmetics to enhance shimmer/opacity. For typical topical use, dermal absorption is very low and it is generally considered acceptable in pregnancy and breastfeeding. If you prefer a cautious approach, avoid inhaling loose powders or sprays.
Sources: General cosmetic ingredient safety references for inert minerals; exposure route considerations for powders/sprays.
An extract of royal jelly used for skin conditioning; bee-product allergy can cause reactions in susceptible users. Allergy is the principal practical concern. No pregnancy- or breastfeeding-specific systemic hazard was identified for normal topical cosmetic exposure.
Sources: European Commission CosIng ingredient inventory; Cosmetic Ingredient Review botanical safety-assessment framework and relevant ingredient-family assessments. No ingredient-specific human pregnancy study of normal topical cosmetic use was identified.
Sodium hyaluronate (hyaluronic acid salt) is used for hydration and cushioning, with very low systemic absorption from topical use and no known pregnancy or breastfeeding concerns at cosmetic concentrations.
Sources: CIR; EU/UK Cosmetics Regulation
Also known as D&C Red No. 33, this certified colour additive is used in cosmetics subject to product-area, concentration, identity, purity and batch-certification requirements. FDA permits specified cosmetic uses but not every route or application area. No pregnancy-specific concern is identified for normal use in a compliant finished cosmetic.
Sources: FDA: Color Additives Permitted for Use in Cosmetics, including D&C Red No. 33 https://www.fda.gov/cosmetics/cosmetic-ingredient-names/color-additives-permitted-use-cosmetics; FDA: Color Additives and Cosmetics Fact Sheet https://www.fda.gov/industry/color-additives/color-additives-and-cosmetics-fact-sheet
Also known as FD&C Blue No. 1 or Brilliant Blue FCF, this certified colour additive is used to colour cosmetic formulas. FDA permits it in cosmetics, including the eye area, when identity, purity, certification and use requirements are met. No pregnancy-specific concern is identified for normal use in a compliant finished cosmetic.
Sources: FDA: Regulatory Status and identity information for FD&C Blue No. 1 / C.I. 42090 https://www.hfpappexternal.fda.gov/scripts/fdcc/index.cfm?id=FDCBLUENO1&set=FoodSubstances; FDA: Color Additives Permitted for Use in Cosmetics https://www.fda.gov/cosmetics/cosmetic-ingredient-names/color-additives-permitted-use-cosmetics
Colour Index name for titanium dioxide. Used as a pigment and (in some products) a mineral UV filter. For typical topical use in creams, lotions and makeup, systemic absorption is expected to be very low. Most concerns discussed in the literature relate to ingestion (E171) or inhalation from fine powders/sprays, and to nanoparticle characterisation. For routine topical cosmetic use, it is generally considered acceptable in pregnancy and breastfeeding; if you prefer a cautious approach, avoid inhaling loose powders or sprays.
Sources: EFSA opinion on titanium dioxide (E171) ingestion context; SCCS cosmetic opinions (incl. inhalation/nano considerations); general dermatology guidance on mineral sunscreens in pregnancy.
Water, Alcohol, Ethylhexyl Methoxycinnamate, Zinc Oxide, Silica, Isopropyl Palmitate, Butylene Glycol, Ethylhexyl Triazone, Diethylamino Hydroxybenzoyl Hexyl Benzoate, Mica, Isononyl Isononanoate, Dipentaerythrityl Tri-Polyhydroxystearate, Triethoxycaprylylsilane, Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine, Sorbitan Stearate, Hydroxyethyl Acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Sodium Acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Isohexadecane, Polysilicone-9, Polysorbate 80, Parfum, Disodium EDTA, Sorbitan Oleate, Tin Oxide, BHT, Royal Jelly Extract, Sodium Hyaluronate, Methylparaben, CI 17200, CI 42090, CI 77891
Ingredient ratings refreshed 15 October 2026. Formulas vary by market and can change. Always compare with your packaging.
The recorded formula includes 4 ingredient entries with risk flags: Ethylhexyl Methoxycinnamate (Medium risk), BHT (Medium risk), Methylparaben (Medium risk), plus others listed in the breakdown. These are ingredient-level flags; they do not replace the stored product assessment or account for every formulation detail. The product score is a stored assessment, not a clinical safety guarantee.
No. The score and risk band describe MamaSkin's pregnancy-focused ingredient screening of this recorded formula. They do not measure SPF, UVA protection, water resistance or whether you have applied enough sunscreen. Use the protection and application instructions on your exact packaging, and review the ingredient flags separately.
31 of 31 ingredient entries on this page have a recorded score, evidence summary and source text. That describes documentation coverage, not proof that the finished formula has been clinically tested during pregnancy.
Only if the ingredient list on your packaging matches the recorded formula shown here. Formulas can differ by market and change over time. Compare the full list, not just the product name; report a mismatch if it differs.
No. This page presents a pregnancy-focused product assessment. Do not infer a breastfeeding conclusion from its score or label; breastfeeding requires a separate assessment of the formula and how it is used.